Letter

Tuberculosis and slim disease in Africa

BMJ 1994; 309 doi: 10.1136/bmj.309.6963.1230b (Published 5 November 1994)
Cite this as: BMJ 1994;309:1230.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. P Godrey-Faussett,
  2. A Mwinga,
  3. M Hosp,
  4. R Baggaley,
  5. J Porter,
  6. R Msiska
  1. Zambart Project, Department of Medicine, University Teaching Hospital, PO Box 50110, Lusaka, Zambia Kara Counselling and Training Trust, Lusaka Department of Clinical Sciences, London School of Hygiene and Tropical Medicine, London National AIDS, STD, and TB Prevention and Control Programme, Ministry of Health, Lusaka

    EDITOR, - S B Lucas and colleagues found that tuberculosis was associated with the wasting that is characteristic of so many deaths related to HIV infection in Africa.1 They conclude that the aim should be prophylaxis or earlier diagnosis and treatment.

    Preventive treatment for tuberculosis in Africa continues to excite controversy. The International Union against Tuberculosis and Lung Diseases and the World Health Organisation issued a joint statement in October 1993 which recommended “isoniazid preventive therapy for individuals with both tuberculosis and HIV infections.”2 Meanwhile, in December 1993, one of the final recommendations of the African regional meeting of the international union was that “Preventive …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular